South and Central America Cerebrospinal Fluid Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Neurological Cente

South and Central America Cerebrospinal Fluid Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Neurological Centers)

The South and Central America cerebrospinal fluid management market is expected to reach US$ 132.52 million by 2028 from US$ 91.06 million in 2021; it is estimated to grow at a CAGR of 5.5% from 2021 to 2028. The growth of the market is attributed to the increasing incidence of cerebrospinal fluid (CSF) leaks and growing developments for CSF management products. However, the risk associated with CSF shunts hinders the market growth.

Brain and spinal injuries are the most common causes of cerebrospinal fluid (CSF) leak in adults, necessitating CSF management. According to the Journal of Neurosurgery, more than 69 million people globally are expected to suffer from traumatic brain injuries annually. Therefore, it is expected that brain and spinal injuries are among the major driving factors for CSF management.

Other leading factor for the CSF leak among adults and elders is high blood pressure, which is majorly caused due to shift in lifestyle and unhealthy habits. Similarly, the increasing number of older people leads to rising incidences of high blood, which ultimately leads to an increasing risk of idiopathic intracranial hypertension (IIH).

The incidences of hydrocephalus are growing significantly across the world. As per an article, “Global Hydrocephalus Epidemiology and Incidence: Systematic Review and Meta-analysis” published in 2018, the gathered incidences of congenital hydrocephalus were high in regions, such as Africa and Latin America. Therefore, the demand for CSF management is likely to grow significantly in the coming years. Growing advancements in the field of medical devices have led to extraordinary developments and innovations. The growing demand for better treatments has resulted in various product developments, resulting in the South and Central America cerebrospinal fluid management market growth. For instance, in January 2020, Biocept initiated the commercial launch of CSF assay and CNSide. CNSide assists in identifying and managing the treatment of metastatic cancers that involves the central nervous system. Furthermore, CNSide is designed for quantitative tumor cell capture and detection method, and these analyses are paired with assays to identify molecular treatment targets.

Countries in South and Central America have faced severe impact of the COVID-19 pandemic due to complete lockdown and restricted import of medical and health care products. Brazil and Argentina recorded the highest number of COVID-19 patients. The countries are famous in the medical tourism sector, and good quality treatments are provided to patients. The pandemic has severely impacted the medical tourism industry in South and Central America.

Countries are significantly dependent on the US and European countries for their medical resources. Therefore, the CSF management was highly influenced by the COVID-19 pandemic. Also, there were several cases of CSF leak during the pandemic due to nasopharyngeal sample collection to detect the presence of coronavirus. Such cases have shown greater concerns for healthcare and medical management to tackle the CSF leaks among such patients. Thus, the COVID-19 pandemic has severely affected the healthcare market and the CSF management market. It

The South and Central America cerebrospinal fluid management market, by product, is segmented into CSF shunts and CSF drainage systems. In 2021, the CSF shunts segment held a larger share of the market. Also, the same segment is estimated to register a higher CAGR during the forecast period due to the growing number of product launches, increasing demand for advanced CSF shunts, and rising incidences of hydrocephalus.

The South and Central America cerebrospinal fluid management market, by end user, is segmented into hospitals, clinics, ambulatory surgical centers, and neurological centers. In 2021, the hospitals segment held the largest share of the market. However, the market for the clinics segment is expected to grow at the fastest rate in the coming years.

.A few of the primary and secondary sources referred to while preparing the report on the South and Central America cerebrospinal fluid management market are Pan American Health Organization (PAHO) and Hydrocephalus Association (H.A.).

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America cerebrospinal fluid management market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South and Central America cerebrospinal fluid management market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.